Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy and radiation with or without panitumumab in stage IIIA non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-16